OHSU radiation oncologist presents promising study findings, launches a third, Medicare-backed study Nima Nabavizadeh, M.D., ...

Telix Pharmaceuticals reports strong Illuccix China results and FDA progress on TLX101-CDx and TLX250-CDx. Read the latest ...

MELBOURNE, Australia and INDIANAPOLIS, /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix') today ...

Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

Management believes that these results support a near-term new drug application submission in China, which it has described ...

A new study published in the International Journal of General Medicine showed that physicians may reliably estimate the ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence ...

MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation to: ...

Surgical site infections (SSIs), particularly intra-abdominal (IAB) infections, are challenging to identify and remain a ...

Researchers developed and validated a machine-learning algorithm for predicting nutritional risk in patients with nasopharyngeal carcinoma.

Platinum-resistant recurrent epithelial ovarian cancer carries a bleak prognosis, with single-agent chemotherapy yielding response rates below 20% ...

The ASX rose by around lunch in the eastern states after Wall Street steadied nerves. Money was flowing back into miners and ...